Literature DB >> 12566655

Blood purification in non-renal critical illness.

John A Kellum1, Rinaldo Bellomo, Ravindra Mehta, Claudio Ronco.   

Abstract

Extracorporeal therapies designed to remove substances from the circulation now include hemodialysis, hemofiltration, hemoadsorption, plasma filtration, cell-based therapies and combinations of any of the above. In recent years, there have been considerable advances in our understanding and technical capabilities, but consensus over the optimal way, and under what conditions to use these therapies does not exist. Consequently, we have initiated a series of conferences under the auspices of the Acute Dialysis Quality Initiative (ADQI). ADQI aims at establishing an evidence-based appraisal and set of consensus recommendations to standardize care and direct further research. The results of previous consensus conferences are available on-line at www.ADQI.net. ADQI conferences have focused on research and management of renal disease. However, extracorporeal therapies are being used or investigated in the management of many other disease processes including systemic inflammation, liver disease, cardiac disease and thrombotic diseases. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566655     DOI: 10.1159/000067862

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  3 in total

1.  Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis.

Authors:  Hong-Li Jiang; Wu-Jun Xue; Da-Qing Li; Ai-Ping Yin; Xia Xin; Chun-Mei Li; Ju-Lin Gao
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

2.  Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock.

Authors:  Taka-Aki Nakada; Shigeto Oda; Ken-Ichi Matsuda; Tomohito Sadahiro; Masataka Nakamura; Ryuzo Abe; Hiroyuki Hirasawa
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

Review 3.  Hemoperfusion: technical aspects and state of the art.

Authors:  Claudio Ronco; Rinaldo Bellomo
Journal:  Crit Care       Date:  2022-05-12       Impact factor: 19.334

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.